Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · IEX Real-Time Price · USD
21.92
-0.10 (-0.43%)
Jul 22, 2024, 10:02 AM EDT - Market open
Enliven Therapeutics Employees
Enliven Therapeutics had 46 employees as of December 31, 2023.
Employees
46
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,730,391
Market Cap
1.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 46 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| OPKO Health | 3,930 |
| Avanos Medical | 3,771 |
| Tarsus Pharmaceuticals | 244 |
| Calliditas Therapeutics AB (publ) | 217 |
| Tango Therapeutics | 140 |
| Cullinan Oncology | 85 |
| Pharvaris | 82 |
| Tyra Biosciences | 49 |
ELVN News
- 7 weeks ago - Enliven Therapeutics to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update - GlobeNewsWire
- 3 months ago - Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia - GlobeNewsWire
- 3 months ago - Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors - GlobeNewsWire
- 4 months ago - Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024 - GlobeNewsWire
- 4 months ago - Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates - GlobeNewsWire
- 4 months ago - Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update - GlobeNewsWire
- 5 months ago - Enliven Therapeutics to Present at TD Cowen's 44th Annual Health Care Conference - GlobeNewsWire